Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effectiveness of DIR/Floortime™ in Children With Autism Spectrum Disorder
Sponsor: GIFT University
Summary
This randomized controlled trial evaluates the efficacy of Integrated DIR/Floortime™ in improving functional emotional development and adaptive behavior in children aged 4-12 years with Autism Spectrum Disorder (ASD). Participants are randomly assigned to either an intervention group receiving DIR/Floortime™ in addition to their ongoing standard therapies or a control group receiving standard therapies alone. Functional emotional development is assessed using the Functional Emotional Assessment Scale (FEAS), while adaptive behavior is evaluated using the Vineland Adaptive Behavior Scales (VABS). The study aims to determine whether integrating DIR/Floortime™ leads to greater improvements in emotional, social, communication, and adaptive functioning compared with standard interventions alone.
Official title: Efficacy of Integrated DIR/Floortime™ for Children With Autism Spectrum Disorder: A Randomized Controlled Trial
Key Details
Gender
All
Age Range
4 Years - 12 Years
Study Type
INTERVENTIONAL
Enrollment
14
Start Date
2026-02-15
Completion Date
2026-08-04
Last Updated
2026-08-11
Healthy Volunteers
No
Conditions
Interventions
DIR/Floortime
Participants received Integrated DIR/Floortime™ intervention for 10 weeks in addition to their ongoing standard therapies. The intervention focused on promoting functional emotional development, communication, social interaction, and adaptive functioning through child-led, relationship-based sessions conducted according to the DIR/Floortime™ model.
Standard therapy
Participants continued to receive routine standard therapeutic services without the addition of DIR/Floortime™ during the 10-week study period.
Locations (1)
SEND Therapy Center
Gujranwala, Punjab Province, Pakistan